Tagrisso (osimertinib) - AstraZeneca
Zegfrovy (sunvozertinib) - AstraZeneca
pemetrexed - Generic mfg.
enozertinib (ORIC-114) - ORIC Pharma
zipalertinib (CLN-081) - Cullinan Therap, Taiho
Ivesa (firmonertinib) - Allist, ArriVent
Gilotrif (afatinib) - Boehringer Ingelheim
P-Loop/αC-Helix Compressing Mutations and Exon 20 Insertions in EGFR-Mutant NSCLC: A Rapidly Evolving Therapeutic Landscape. (PubMed, J Clin Oncol) - Sep 15, 2026 - "EGFR PACC and ex20ins are established subgroups of kinase domain mutations, distinct from classical mutations, due to structure and responsiveness to available TKIs." 
Journal • Review • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • EGFR
http://www.ncbi.nlm.nih.gov/pubmed/42735369
 
Alfredo Addeo; Caicun Zhou; Federico Monaca; Igor Randulfe; John V Heymach; Raffaele Califano; Xiuning Le
 
Sep 15, 2026
 
Prev Next